94
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Premenstrual syndrome as a risk factor for relapse in GHB dependent patients: a case series

, , , & ORCID Icon
Pages 416-420 | Received 09 Oct 2019, Accepted 21 Jan 2020, Published online: 10 Feb 2020

References

  • EMCDDA. (2016). Statistical bulletin 2016 [Online]. Retrieved from www.emcdda.europa.eu. http://www.emcdda.europa.eu/data/stats2016
  • Endicott, J., Nee, J., & Harrison, W. (2006). Daily Record of Severity of Problems (DRSP): Reliability and validity. Archives of Women’s Mental Health, 9, 41–49. doi:10.1007/s00737-005-0103-y
  • Epperson, C. N., Haga, K., Mason, G. F., Sellers, E., Gueorguieva, R., Zhang, W., … Krystal, J. H. (2002). Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry, 59, 851–858. doi:10.1001/archpsyc.59.9.851
  • Gonzalez, A., & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology, 19, 195–204. doi:10.1177/0269881105049041
  • Halbreich, U., & Endicott, J. (1985). Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatrica Scandinavica, 71, 331–338. doi:10.1111/acp.1985.71.issue-4
  • Halbreich, U., Petty, F., Yonkers, K., Kramer, G. L., Rush, A. J., & Bibi, K. W. (1996). Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. The American Journal of Psychiatry, 153, 718–720.
  • Kamal, R. M., Schellekens, A., de Jong, C. A., & Dijkstra, B. A. (2015). Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: An open label study. BMC Psychiatry, 15, 91. doi:10.1186/s12888-015-0471-4
  • Kendler, K. S., Karkowski, L. M., Corey, L. A., & Neale, M. C. (1998). Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. American Journal of Psychiatry, 155, 1234–1240. doi:10.1176/ajp.155.9.1234
  • Lloyd, K. G., Zivkovic, B., Scatton, B., Morselli, P. L., & Bartholini, G. (1989). The gabaergic hypothesis of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, 341–351. doi:10.1016/0278-5846(89)90123-1
  • Moran-Santa Maria, M. M., Flanagan, J., & Brady, K. (2014). Ovarian hormones and drug abuse. Current Psychiatry Reports, 16, 511. doi:10.1007/s11920-014-0511-7
  • O’Brien, P. M., Backstrom, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., … Yonkers, K. (2011). Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Archives of Women’s Mental Health, 14, 13–21. doi:10.1007/s00737-010-0201-3
  • O’Keane, V., & Dinan, T. G. (1994). Growth hormone responses to GABAB receptor stimulation throughout the menstrual cycle of healthy females. Human Psychopharmacology, 9, 129–134. doi:10.1002/hup.470090207
  • Potter, J., Bouyer, J., Trussell, J., & Moreau, C. (2009). Premenstrual syndrome prevalence and fluctuation over time: Results from a French population-based survey. Journal of Women’s Health, 18, 31–39. doi:10.1089/jwh.2008.0932
  • Schmidt, P. J., Nieman, L. K., Grover, G. N., Muller, K. L., Merriam, G. R., & Rubinow, D. R. (1991). Lack of effect of induced menses on symptoms in women with premenstrual syndrome. The New England Journal of Medicine, 324, 1174–1179. doi:10.1056/NEJM199104253241705
  • Steiner, M., Macdougall, M., & Brown, E. (2003). The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women’s Mental Health, 6, 203–209. doi:10.1007/s00737-003-0018-4
  • Sundstrom, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., & Backstrom, T. (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology, 67, 126–138. doi:10.1159/000054307
  • Van der Leij, F., Schultz, W. C., van de Wiel, H., & van Leeuwen, J. H. (2010). The premenstrual syndrome. Nederlands Tijdschrift Voor Geneeskunde, 154, A1341.
  • Wardlaw, S. L., Thoron, L., & Frantz, A. G. (1982). Effects of sex steroids on brain beta-endorphin. Brain Research, 245, 327–331. doi:10.1016/0006-8993(82)90815-0
  • Wisselink, D. J., Kuijpers, W. G. T., & Mol, A. (2014). Highlights addiction care 2013. Houten, The Netherlands: National Alcohol and Drugs Information System (LADIS).
  • Zvosec, D. L., Smith, S. W., Porrata, T., Strobl, A. Q., & Dyer, J. E. (2011). Case series of 226 gamma-hydroxybutyrate-associated deaths: Lethal toxicity and trauma. The American Journal of Emergency Medicine, 29, 319–332. doi:10.1016/j.ajem.2009.11.008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.